2311
194
133
144
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T4661 | PKG drug G1 | PKA | |
PKG drug G1 targets PKG Iα C42. PKG drug G1 can couple to vasodilation and blood pressure lowering by a C42 PKG Iα-independent mechanism. | |||
T23757 | Ascorbic acid, rutoside drug combination | Rutinoscorbin,Rutascorbin,Ruta C 60,Cerutin | |
Ascorbic acid, rutoside drug combination is used for treating diabetic retinopathy. | |||
T15058 | DBCO-amine | ||
DBCO-amine is a cleavable ADC linker used in antibody-drug conjugates (ADCs) synthesis[1]. | |||
T22334 | FMOC-3VVD-OH | Others | |
FMOC-3VVD-OH is an active chemical. | |||
T15098 | Deruxtecan | Others | |
Deruxtecan is an ADC drug-linker conjugate consisting of a derivative of DX-8951 (DXd) and a maleimide-GGFG peptide linker for the synthesis of DS-8201 and U3-1402. | |||
T4346 | SPDB | Others | |
SPDB is a small fragment linked to DM4 conjugates. It conjugates to antibodies utilizing disulfide linkers: anti-EGFR-SPDB-DM4 has been widely used. | |||
T8547 | DCBA | Drug Metabolite | |
DCBA, an endogenous metabolite of the insect repellent N-N-diethyl-meta-toluamide (DEET), is utilized to evaluate DEET exposure through its concentration levels in urine. | |||
T9014 | SKI-178 | Apoptosis , S1P Receptor | |
SKI-178 is a sphingosine kinase 1 (SphK1) inhibitor with IC50 of 0.1-1.8 μM. It induces prolonged mitosis followed by apoptotic cell death through the intrinsic apoptotic cascade. The sustained activation of CDK1 during ... | |||
T17389 | AMAS | Others | |
AMAS is a non-claevable heterobifunctional crosslinker with NHS ester and maleimide groups that enables covalent conjugation of amine- and sulfhydryl-containing molecules. | |||
T15179 | DTSSP Crosslinker | Others | |
DTSSP Crosslinker is a cleavable ADC linker and can be used to synthesize antibody-drug conjugates (ADCs). | |||
T15176 | DSS Crosslinker | Others | |
DSS Crosslinker is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).It is a homobifunctional crosslinker that is cell membrane permeable. DSS crosslinker has amine-reactive NHS esters a... | |||
T3540 | IMR-1A | Gamma-secretase , Drug Metabolite | |
IMR-1A is the metabolite of IMR-1 which is a novel class of Notch inhibitors targeting the transcriptional activation with IC50 of 6 μMol/L. | |||
T16218 | N-Boc-PEG5-bromide | Others , PROTAC Linker | |
N-Boc-PEG5-bromide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1]. | |||
T18723 | Succinic anhydride | Others | |
Succinic anhydride is a cyclic anhydride. Succinic anhydride acts as a nonclaevable ADC linker. Succinic anhydride can react with compound 4 to link the prodrug to an amine or hydroxy 1 group of a targeting polypeptide. | |||
T13621 | CNDAC hydrochloride | Nucleoside Antimetabolite/Analog , Others , Drug Metabolite | |
CNDAC hydrochloride, a nucleoside analog, is a metabolite of the sapacitabine. | |||
T0150 | Hydroxyhexamide | (±)-Hydroxyhexamid | Potassium Channel , Drug Metabolite |
Hydroxyhexamide ((±)-Hydroxyhexamid) is a pharmacologically active metabolite of Acetohexamide, used as a hypoglycemic agent. | |||
T14933 | Cetaben | Others | |
Cetaben is a PPARα-independent peroxisome proliferator and is a non-fibrate hypolipidemic drug. It potent reduces the concentration of cholesterol and triglycerides. | |||
T37514 | Hydroxy Dimetridazole | Drug Metabolite | |
Dimetridazole is a nitroimidazole-based compound with antibacterial and anticoccidial activity. It was once widely used in the treatment of parasitic infections in poultry, cattle, swine and farmed fish until suspected t... | |||
T4989 | Fosfomycin Tromethamine | Antibacterial , Antibiotic | |
An antibiotic produced by Streptomyces fradiae. | |||
T22278 | BOC-Dap-NE | Others | |
Boc-Dap-NE used in the synthesis of antibody-drug conjugates (ADCs).It is a cleavable ADC linker | |||
T12490 | Pitavastatin lactone | Others | |
Pitavastatin lactone is a major Pitavastatin metabolite in humans. Pitavastatin is a potent competitive inhibitor of HMG-CoA reductase little metabolized in hepatic microsomes. | |||
T10138 | 4-Desmethoxy Omeprazole | Drug Metabolite | |
4-Desmethoxy Omeprazole is the active metabolite of Omeprazole. Omeprazole is a proton pump inhibitor (PPI). Omeprazole shows competitive inhibition of CYP2C19 activity (Ki: 2 to 6 μM). | |||
T15171 | DSG Crosslinker | Others | |
DSG Crosslinker is a cleavable ADC linker used in antibody-drug conjugates (ADCs) synthesis. | |||
T15175 | DSP Crosslinker | Others | |
DSP Crosslinker is a cleavable ADC linker, used in antibody-drug conjugates (ADCs) synthesis[1]. | |||
T18868 | Val-Cit | Others | |
Val-Cit is a cleavable ADC linker. Val-Cit is used in the synthesis of antibody-drug conjugates (ADCs). | |||
T37600 | Dasatinib N-oxide | Others | |
Dasatinib N-oxide is a major metabolite of the Abl and Src kinase inhibitor dasatinib.It is also a potential impurity in commercial preparations of dasatinib[1][2]. | |||
T18867 | Val-Cit-PAB-MMAE | ||
Val-Cit-PAB-MMAE is a drug-linker conjugate for ADC. Val-Cit-PAB-MMAE contains the ADCs linker (peptide Val-Cit-PAB) and a potent tubulin inhibitor MMAE . MMAE a potent mitotic inhibitor by inhibiting tubulin polymerizat... | |||
T6741 | SPDP | SPDP Crosslinker | Others |
SPDP is a short-chain crosslinker, which is used for amine-to-sulfhydryl conjugation via NHS-ester and pyridyldithiol reactive groups that form cleavable (reducible) disulfide bonds with cysteine sulfhydryls. SPDP could ... | |||
T13131 | Tert-Buthyl Pitavastatin | HMG-CoA Reductase | |
tert-Buthyl Pitavastatin is Pitavastatin metabolite. Pitavastatin is a potent inhibitor of HMG-CoA reductase. | |||
T8924 | MFCD28987368 | Others | |
MFCD28987368 is a degradable ADC linker that can be used in the synthesis of antibody coupled drugs (ADCs). | |||
T18479 | NH-bis(C1-Boc) | Others | |
NH-bis(C1-Boc)is a uncleavable linker. NH-bis can be used for antibody-drug conjugates (ADC). | |||
T4678 | Fmoc-Val-Cit-PAB | Others | |
Fmoc-Val-Cit-PAB is a linker for antibody-drug-conjugation (ADC). | |||
T17691 | Boc-Val-Cit-OH | Others | |
Boc-Val-Cit-OH is a cleavable ADC linker used in antibody-drug conjugates (ADCs) synthesis. | |||
T18308 | MC-Gly-Gly-Phe | ||
MC-Gly-Gly-Phe is a cleavable linker. MC-Gly-Gly-Phe can be used for antibody-drug conjugates (ADC). | |||
T17693 | Boc-Val-Cit-PAB | Others | |
Boc-Val-Cit-PAB is a cleavable ADC linker. Boc-Val-Cit-PAB used in the synthesis of antibody-drug conjugates (ADCs). | |||
T17952 | Fmoc-Gly-Gly-OH | Others | |
Fmoc-Gly-Gly-OH is a cleavable ADC linker. Fmoc-Gly-Gly-OH can be used in the synthesis of antibody-drug conjugates (ADCs). | |||
T8722 | IKIX1 | Antifungal | |
iKIX1 is an Pdr1-dependent gene activation. It re-sensitizes drug-resistant C. glabrata to azole antifungals in vitro and in animal models for disseminated and urinary tract C. glabrata infection. | |||
T17213 | Val-cit-PAB-OH | Others | |
Val-cit-PAB-OH is an ADC linker that is cleavable. | |||
T17372 | Ald-Ph-NHS ester | Others | |
Ald-Ph-NHS ester is a non-cleavable linker used in antibody-drug-conjugation (ADC). | |||
T9344 | 3-Amino-2-oxazolidinone | Others , Endogenous Metabolite | |
3-Amino-2-oxazolidinone (AOZ) is the metabolite of Furazolidone . It is always be detected as a indicator of furazolidone residues in vivo. | |||
T16045 | Methotrexate metabolite | DAMPA | Antifolate , Drug Metabolite |
Methotrexate metabolite (DAMPA) (DAMPA) is the active metabolite of Methotrexate. Methotrexate is a folic acid antagonist. Methotrexate is used as a chemotherapeutic agent and immunosuppressant. | |||
T16225 | N-Hydroxysulfosuccinimide sodium | ||
N-Hydroxysulfosuccinimide sodium is a non-cleavable ADC linker used in antibody-drug conjugates (ADCs) synthesis. | |||
T16031 | McMMAF | Maleimidocaproyl monomethylauristatin F | Microtubule Associated |
McMMAF is a protective group-conjugated MMAF. MMAF is a potent tubulin polymerization inhibitor.It is a MMAF derivative having a Maleimidocaproyl linker (MC linker), which is ready to conjugate to antibody or other prote... | |||
T17983 | Fmoc-Val-Cit-PAB-MMAE | Others | |
Fmoc-Val-Cit-PAB-MMAE is consisted of the ADCs linker (Fmoc-Val-Cit-PAB) and potent tubulin inhibitor (MMAE). Fmoc-Val-Cit-PAB-MMAE is a drug-linker conjugate for ADC. | |||
T18728 | Sulfo-SMCC sodium | Others | |
Sulfo-SMCC sodium, a widely utilized non-cleavable, hetero-bifunctional crosslinker for antibody-drug conjugates (ADCs), features both N-hydroxysuccinimide (NHS) ester and maleimide groups. These functionalities enable i... | |||
T7767 | FMoc-Val-Cit-PAB-PNP | Others | |
Fmoc-Val-Cit-PAB-PNP is a linker for Antibody-Drug-Conjugation (ADC). | |||
T17953 | Fmoc-Gly-Gly-Phe-OtBu | Others | |
Fmoc-Gly-Gly-Phe-OtBu is a cleavable ADC linker. Fmoc-Gly-Gly-Phe-OtBu can be used in the synthesis of antibody-drug conjugates (ADCs). | |||
T18540 | Phe-Lys(Trt)-PAB | Others | |
Phe-Lys(Trt)-PAB is a cathepsin-cleavable linker utilized in the development of antibody-drug conjugates (ADCs)[1], serving as a crucial component for facilitating the release of therapeutic agents within targeted cells. | |||
T18321 | Mc-Val-Cit-PAB-Cl | Others | |
Mc-Val-Cit-PAB-Cl, a cleavable ADC linker, is utilized in the conjugation of MMAE and antibodies to produce compounds such as antibody-MC-vc-MMAE (e.g., anti-CD22-MC-VC-PABC-MMAE), which demonstrate cytotoxicity with IC5... | |||
T38953 | Azido-C6-OH | ||
Azido-C6-OH is a cleavable ADC linker used to synthesize antibody-drug conjugates (ADCs). |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
Fr13756 | Isonicotinic acid | Endogenous Metabolite , Drug Metabolite | |
Isonicotinic acid is a metabolite of Isoniazid.Isonicotinic acid is a useful isomer of nicotinic acid. Isoniazid is converted to Isonicotinic acid by hydrazinolysis, with the biotransformation also to be catalyzed by cyt... | |||
T13539 | Allopurinol riboside | Others , Endogenous Metabolite , Parasite , Drug Metabolite | |
Allopurinol riboside is a metabolite of allopurinol with potency against parasites. Allopurinol riboside competitively inhibits the action of purine nucleoside phosphorylase on inosine with a Ki of 277 μM. | |||
T8115 | Menthofuran | Others | |
Menthofuran is a natural product. | |||
TN4660 | Niranthin | Anti-infection , HBV , PAFR , Topoisomerase | |
Niranthin is a potent anti-leishmanial agent, inhibits the relaxation activity of heterodimeric type IB topoisomerase of L. donovani and acts as a non-competitive inhibitor interacting with both subunits of the enzyme. N... | |||
T9784 | Docosanedioic acid | PROTAC Linker | |
BEHENIC ACID is a alkyl-chain-based PROTAC linker. BEHENIC ACID is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | |||
TN1740 | Homoeriodictyol | 5-HT Receptor , transporter , Sodium Channel , Drug Metabolite | |
Homoeriodictyol, a naturally occurring, bitter-masking flavanone, as a promising agent to increase appetite and food intake. The flavanone homoeriodictyol can increase SGLT-1-mediated glucose uptake but decrease serotoni... | |||
TN6512 | Tectol | Transferase , Parasite | |
Tectol has anti-plasmodial activity, it as a moderately active growth inhibitor with an IC50 3.44±0.20μM. It exhibited significant activity against human leukemia cell lines HL60 and CEM. Tectol may cause itchy dermatiti... | |||
T8175 | DL-Laudanosine | Laudanosine | Others , Drug Metabolite |
DL-Laudanosine (Laudanosine) is a recognized metabolite of atracurium and cisatracurium. | |||
T8262 | Fosfomycin sodium | Fosfomycin Disodium | Antibacterial , Antibiotic |
Fosfomycin sodium is a bactericidal, low-molecular weight, broad-spectrum antibiotic, with putative activity against several bacteria, including multidrug-resistant Gram-negative bacteria, by irreversibly inhibiting an e... | |||
T12095 | Monomethyl fumarate | GPR , Drug Metabolite | |
Monomethyl fumarate is a potent agonist of GPR109A . | |||
T4820 | Maleimide | 2,5-Pyrroledione | Others |
Maleimide (2,5-Pyrroledione) (2,5-Pyrroledone) is a new nanoparticle surface functional group which favors easy conjugation with cell penetration peptides. The conjugation is enabled via click chemistry to preserve its b... | |||
T4000 | (±)-Equol | Equol,(R,S)-Equol | Estrogen Receptor/ERR , Estrogen/progestogen Receptor , Drug Metabolite |
(±)-Equol ((R,S)-Equol) is a non-steroidal estrogen produced from the metabolism of the isoflavonoid phytoestrogen daidzen by human intestinal microflora. The estrogen receptor (ER) agonist activity of the naturally occu... | |||
TN1742 | Homovanillyl alcohol | TNF , Drug Metabolite | |
Homovanillyl alcohol is a biological metabolite of Hydroxytyrosol. Hydroxytyrosol is a phenolic compound that is present in virgin olive oil (VOO) and wine. Homovanillyl alcohol displays high scavenging activities, it pr... | |||
T2149 | Vinburnine | Eburnalritardo,L-Eburnamonine,Vincamone,(-)-Eburnamonine,(-)-Vincamone | Others , Drug Metabolite |
Vinburnine (Eburnalritardo) is a vasodilator. Vinburnine is a vinca alkaloid and a metabolite of vincamine. | |||
T16338 | Norgestimate metabolite Norelgestromin | 17-Deacetyl norgestimate,17-Deacylnorgestimate | Drug Metabolite |
Norgestimate metabolite Norelgestromin (17-Deacylnorgestimate) is one of the active metabolites of norgestimate.It is a steroidal progestin used in contraceptive patches, where it is combined with the estrogen ethinyl es... | |||
T8149 | Dobutamine hydrochloride | Dobutamine (hydrochloride) | Adrenergic Receptor |
Dobutamine hydrochloride (Dobutamine (hydrochloride)) is a catecholamine that acts as a β-adrenergic receptor agonist with potent positive inotropic effects. | |||
T6293 | Mycophenolate Mofetil | TM-MMF,RS 61443 | Apoptosis , Dehydrogenase , Drug Metabolite |
Mycophenolate Mofetil (TM-MMF), an immunosuppressive agent, is the 2-morpholinoethyl ester of mycophenolic acid (MPA), and an inhibitor of inosine monophosphate dehydrogenase (IMPDH). | |||
T7174 | Urolithin A | Apoptosis , Reactive Oxygen Species , DNA/RNA Synthesis , Endogenous Metabolite , Autophagy , Drug Metabolite | |
Urolithin A is a secondary metabolite of ellagic acid, a polyphenolic antioxidant, that has antiproliferative, anti-inflammatory, and anti-oxidant properties. | |||
T8183 | Deslanoside | Desacetyllanatoside C,Deacetyllanatoside C | ATPase , Drug Metabolite |
Deslanoside (Desacetyllanatoside C) is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms. Deslanoside inhibits the Na-K-ATPase membrane p... | |||
T0983 | Penicillamine | d-penicillamin,Dimethyl Cysteine,Artamine,D-(-)-Penicillamine | Antibiotic |
Penicillamine (Artamine), possessing antineoplastic properties, induces apoptosis by a p53-mediated mechanism and inhibits angiogenesis by chelating with copper, a cofactor for angiogenesis. Artamine is a beta dimethyl a... | |||
T5320 | Tulipalin A | α-methylene-γ-butyrolactone,2-Methylenebutyrolactone | Others , Drug Metabolite |
Tulipalin A (α-methylene-γ-butyrolactone) (2-Methylenebutyrolactone) which has some phytotoxicity is a natural compound extracted from Tulipa gesneriana. | |||
T17143 | Toyocamycin | Vengicide | Apoptosis , Others , IRE1 , Antibiotic , Antifungal |
Toyocamycin (Vengicide) is an adenosine analog produced by Actinomycete, acts as an XBP1 inhibitor, inhibits IRE1α-induced ATP-dependent XBP1 mRNA cleavage (IC50: 80 nM). Toyocamycin induces apoptosis. | |||
T13808 | P-Coumaric Acid Ethyl Ester | Ethyl (E)-p-hydroxycinnamate,Ethyl trans-4-hydroxycinnamate | Others , Drug Metabolite |
p-Coumaric Acid Ethyl Ester (Ethyl (E)-p-hydroxycinnamate) is the ethyl ester of p-Coumaric acid. p-Coumaric Acid is a common dietary polyphenol and also a potent immunosuppressive agent in treating autoimmune inflammato... | |||
T0617 | Nicotinamide N-oxide | Nicotinamide-N-oxide,Nicotinamide 1-oxide,1-oxynicotinamide | c-Myc , Endogenous Metabolite , CXCR , Drug Metabolite |
Nicotinamide N-oxide (Nicotinamide 1-oxide) is recognized as an in vivo metabolite of nicotinamide which is a precurser of nicotinamide-adenine dinucleotide (NAD+) in animals. The enzyme that catalyzes the reduction of n... | |||
T4710 | 3-Methoxytyramine hydrochloride | 3-O-methyl Dopamine hydrochloride,3-O-methyl Dopamine hydrochloride) | Others , Endogenous Metabolite , Drug Metabolite |
3-Methoxytyramine hydrochloride (3-O-methyl Dopamine hydrochloride) is an inactive metabolite of dopamine which can activate trace amine associated receptor 1 (TAAR1). 3-methoxytyramine can be found primarily in human br... | |||
T3797 | Isosilybin | Isosilybinin,Isosilibinin,Silymarin,Silybin B,Q-100795 | P450 |
Isosilybin (Isosilibinin) and Silybin might be suitable candidates to design potent PXR antagonists to prevent drug-drug interactions via CYP3A4 in cancer patients. | |||
T3669 | Curcumenol | (+)-Curcumenol | P450 |
Curcumenol ((+)-Curcumenol), one of the major components of Zedoary turmeric oil, is an antibiotic drug which has anti-Y, anti-inflammation activity. Curcumenol may be safely used without inducing metabolic drug-drug int... | |||
T3212 | Digoxigenin | Others | |
Digoxigenin, a therapeutic drug belonging to the group of cardiac glycosides, is widely used in the management of congestive heart failure and other cardiac diseases | |||
TWO2771 | 2-Adamantanol | Adamantan-2-Ol,2-Hydroxyadamantane | Others |
2-Adamantanol (2-Hydroxyadamantane) was used to synthesize antiallergic drug Mizolastine. | |||
T5567 | Tetradecanedioic acid | Tetradecanedicarboxylate | Others , Endogenous Metabolite |
Tetradecanedioic acid (Tetradecanedicarboxylate) is a long-chain fatty acid that is a type of endogenous metabolite. It can serve as a candidate biomarker for drug-drug interactions mediated by organic anion transporting... | |||
T1468 | Lornoxicam | Ro 13-9297,Chlortenoxicam,TS110 | COX , Endogenous Metabolite |
Lornoxicam (Chlortenoxicam) (chlortenoxicam) is a new nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory, and antipyretic properties. Lornoxicam differs from other oxicam co... | |||
T6S2243 | Alisol A 24-acetate | Alisol A 24-monoacetate,Alisol A monoacetate | Others |
1. Alisol A 24-acetate (Alisol A monoacetate) has been determined for the quality control of this crude drug. | |||
T3820 | Iridin | Lridin | Others |
Iridin (Lridin) is major active ingredient of Iris dichotoma which could be used as the drug for pain, inflammation treatment | |||
T0681 | Rifampicin | Rifamycin AMP,Rimactane,Rifampin | Influenza Virus , DNA/RNA Synthesis , Antibacterial , Antibiotic , Antifection |
Rifampicin (Rifamycin AMP) is an antibacterial drug of the class of rifamycin. | |||
T22286 | Cyanosafracin B | Cyanoquinonamine,CBR28-1 | Others |
Cyanosafracin B (Cyanoquinonamine) is a compound which can be used in the synthesis of ecteinascidin ET-743 (an antitumor chemotherapy drug). | |||
T7936 | Benzopinacole | Others | |
Benzopinacole is an anti-amoeba drug that can be used as an intermediate to synthesize a variety of compounds. | |||
T3327 | Artemotil | SM-227,β-Arteether,Beta-Arteether,Arteether,(+)-Arteether | CXCR , CCR , Parasite |
Artemotil (SM-227) is a new, fast-acting antimalarial drug. | |||
T10147 | 4-Hydroxymephenytoin | (+/-)-4'-Hydroxymephenytoin | Others , Drug Metabolite |
4-Hydroxymephenytoin ((+/-)-4'-Hydroxymephenytoin) is the metabolism of an antiepileptic drug mephenytoin. Mephenytoin is used as a CYP2C19 substrate. | |||
T4S0647 | Butylphthalide | 3-Butylphthalide,3-n-Butylphathlide,3-n-Butylphthalide | Others |
Butylphthalide (3-Butylphthalide) is an anti-cerebral-ischemia drug; first isolated from the seeds of Apium graveolens Linn. | |||
T4S0051 | Coptisine sulfate | Indoleamine 2,3-Dioxygenase (IDO) | |
1. Coptisine sulfate has growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program. | |||
T2959 | Ginsenoside Rh2 | 20(S)-Rh2,20S-Ginsenoside Rh2,20(S)-Ginsenoside Rh2 | Apoptosis , EGFR , Caspase , Endogenous Metabolite |
Ginsenoside Rh2 (20(S)-Ginsenoside Rh2), an extract of red Panax ginseng, is a potent anti-inflammatory and anticancer drug. | |||
TN3967 | Epieriocalyxin A | ERK , BCL , ROS , Caspase , DNA/RNA Synthesis , JNK | |
Epieriocalyxin A can suppress Caco-2 colon cancer cell growth. It could be a potential drug for colon cancer therapy in the future. | |||
T0254 | Probucol | DH-581 | Virus Protease , ABC , Lipid |
Probucol (DH-581), an anti-hyperlipidemic drug, can lower the level of cholesterol in the bloodstream by increasing the LDL catabolic rate. | |||
T1152 | Albendazole | SKF-62979 | HIF/HIF Prolyl-Hydroxylase , Microtubule Associated , Antibiotic , Parasite |
Albendazole (SKF-62979) is used as a drug indicated for the treatment of a variety of worm infestations. | |||
T1381 | Milbemycin oxime | Others , Antibiotic , Parasite | |
Milbemycin oxime is a broad spectrum antiparasitic, used as a veterinary drug. | |||
TQ0152 | Dalfopristin | RP54476 | Antibacterial , Antibiotic |
Dalfopristin (RP54476) is a semi-synthetic streptogramin antibiotic. Quinupristin/Dalfopristin (Q/D) is used for the treatment of multi-drug resistant Enterococcus faecium infections. | |||
TN1529 | Coumarin 6 | Coumarin VI | Others |
Coumarin 6 (Coumarin VI) is a fluorescent dye frequently used to facilitate the traceability of drug delivery systems in vitro. | |||
TN1296 | 5-Feruloylquinic acid | 5-O-Feruloylquinic acid,5-FQA | Tyrosinase , Sirtuin |
5-Feruloylquinic acid (5-FQA) is a potent Sirt1 agonist, it is a potential lead compound that can be further tested in drug development process for diseases associated with aging. | |||
T5132 | 9-dihydro-13-acetylbaccatin III | 13-Acetyl-9-dihydrobaccatin III,9-DHAB III | Apoptosis |
9-dihydro-13-acetylbaccatin III (9-DHAB III)is an apoptosis inducer. It shows cytotoxicity against the MCF7 cell line and drug-resistant cell line MCF7-ADR. | |||
T3021 | Bulleyaconitine A | Bulleyaconi cine A | Sodium Channel |
Bulleyaconitine A (Bulleyaconi cine A), an analgesic and antiinflammatory drug isolated from Aconitum plants, has several potential targets, such as voltage-gated Na+ channels. | |||
------------------------ More ------------------------ |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01884 | MMP-8 Protein, Human, Recombinant | Human | HEK293 |
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that degrade components of the extracellular matrix (ECM) and play essential roles in various physiological processes such as morphogenesis, ... | |||
TMPY-02062 | SULT1A1 Protein, Human, Recombinant (His) | Human | E. coli |
Sulfate conjugation catalyzed by cytosolic sulfotransferase (SULT) enzymes. The SULTs are Phase II drug-metabolizing enzymes that catalyze the addition of a sulfuryl moiety to both endogenous compounds, including steroid... | |||
TMPY-01776 | Carboxylesterase 2/CES2 Protein, Human, Recombinant (His) | Human | HEK293 |
Carboxylesterase 2 (CES2) is a member of the carboxylesterase family and belongs to the multigene family. Carboxylesterase 2 is responsible for the hydrolysis of ester- and amide-bond-containing drugs such as cocaine and... | |||
TMPY-00971 | CEACAM6 Protein, Human, Recombinant (His) | Human | HEK293 |
Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6), also known as nonspecific crossreacting antigen (NCA) and CD66c, is one of seven human CEACAM family members within the immunoglobulin superfamily. It ... | |||
TMPY-05850 | CEACAM6 Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 |
Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6), also known as nonspecific crossreacting antigen (NCA) and CD66c, is one of seven human CEACAM family members within the immunoglobulin superfamily. It ... | |||
TMPY-02702 | ASGR1 Protein, Human, Recombinant (His) | Human | HEK293 |
The asialoglycoprotein receptor (ASGPR), an endocytotic cell surface receptor expressed by hepatocytes, is triggered by triantennary binding to galactose residues of macromolecules such as asialoorosomucoid (ASOR). ASGPR... | |||
TMPY-05542 | ASGR1 Protein, Human, Recombinant (His), Biotinylated | Human | HEK293 |
The asialoglycoprotein receptor (ASGPR), an endocytotic cell surface receptor expressed by hepatocytes, is triggered by triantennary binding to galactose residues of macromolecules such as asialoorosomucoid (ASOR). ASGPR... | |||
TMPY-02412 | ENO1 Protein, Human, Recombinant (His) | Human | E. coli |
The ENO1 gene encodes a multifunctional enzyme that has been identified as a key component of the glycolytic pathway. ENO1 overexpression and post-translational modifications could be of diagnostic and prognostic value ... | |||
TMPY-04493 | BCMA/TNFRSF17 Protein, Human, Recombinant (rFc) | Human | HEK293 |
Tumor necrosis factor receptor superfamily, member 17 (TNFRSF17), also known as B cell maturation antigen (BCMA) or CD269 antigen, is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in... | |||
TMPY-05319 | BCMA/TNFRSF17 Protein, Human, Recombinant (His) | Human | HEK293 |
Tumor necrosis factor receptor superfamily, member 17 (TNFRSF17), also known as B cell maturation antigen (BCMA) or CD269 antigen, is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in... | |||
TMPY-01478 | HSP90 alpha Protein, Human, Recombinant | Human | E. coli |
Heat shock protein 90 (90 kDa heat-shock protein, HSP90) is a molecular chaperone involved in the trafficking of proteins in the cell. It is a remarkably versatile protein involved in the stress response and normal homoe... | |||
TMPY-05568 | BCMA/TNFRSF17 Protein, Human (His & hFc), PE conjugated | Human | HEK293 |
Tumor necrosis factor receptor superfamily, member 17 (TNFRSF17), also known as B cell maturation antigen (BCMA) or CD269 antigen, is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in... | |||
TMPY-03213 | BCMA/TNFRSF17 Protein, Rhesus, Recombinant (hFc) | Rhesus | HEK293 |
Tumor necrosis factor receptor superfamily, member 17 (TNFRSF17), also known as B cell maturation antigen (BCMA) or CD269 antigen, is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in... | |||
TMPY-00443 | EPO/Erythropoietin Protein, Mouse, Recombinant | Mouse | HEK293 |
Erythropoietin is a member of the EPO / TPO family. It is a secreted, glycosylated cytokine composed of four alpha helical bundles. Erythropoietin can be found in the plasma and regulates red cell production by promoting... | |||
TMPY-00639 | EPO/Erythropoietin Protein, Human, Recombinant (hFc) | Human | HEK293 |
Erythropoietin is a member of the EPO / TPO family. It is a secreted, glycosylated cytokine composed of four alpha helical bundles. Erythropoietin can be found in the plasma and regulates red cell production by promoting... | |||
TMPY-00820 | IgG1 Fc Protein, Human, Recombinant (C103S) | Human | HEK293 |
As a monomeric immunoglobulin that is predominately involved in the secondary antibody response and the only isotype that can pass through the human placenta, Immunoglobulin G (IgG) is synthesized and secreted by plasma ... | |||
TMPY-02457 | IL-2 Protein, Rat, Recombinant | Rat | E. coli |
Interleukin-2, also known as a T-cell growth factor, TCGF, Aldesleukin, and IL2, is a secreted protein that belongs to the IL-2 family. Interleukin-2 / IL-2 was the first interleukin molecule to be discovered. Interleuki... | |||
TMPY-02788 | IL-2 Protein, Mouse, Recombinant | Mouse | E. coli |
Interleukin-2, also known as a T-cell growth factor, TCGF, Aldesleukin, and IL2, is a secreted protein that belongs to the IL-2 family. Interleukin-2 / IL-2 was the first interleukin molecule to be discovered. Interleuki... | |||
TMPY-05321 | CYP3A4 Protein, Human, Recombinant (His) | Human | E. coli |
CYP3A4 is an important member of the cytochrome P450 enzyme superfamily, with 33 allelic variants. Human cytochrome P450 3A4 (CYP3A4) is an important drug metabolizing enzyme involved in a number of drug-drug and food-dr... | |||
TMPH-03139 | MDR1 Protein, Plasmodium falciparum, Recombinant (His & SUMO) | Plasmodium falciparum | E. coli |
Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells. | |||
TMPY-02271 | TRXR1/TXNRD1 Protein, Human, Recombinant (aa 161-647, His) | Human | E. coli |
Thioredoxin reductase 1 (TXNRD1) which is a selenocysteine-containing protein is overexpressed in many malignancies. TXNRD1 plays a key role in regulating cell growth and transformation, and protects cells against oxidat... | |||
TMPH-01711 | ABCC1 Protein, Human, Recombinant (His) | Human | E. coli |
Mediates export of organic anions and drugs from the cytoplasm. Mediates ATP-dependent transport of glutathione and glutathione conjugates, leukotriene C4, estradiol-17-beta-o-glucuronide, methotrexate, antiviral drugs a... | |||
TMPK-00619 | FcRH5/FcRL5 Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated | Human | HEK293 |
FcRH5 is a cell surface marker enriched on malignant plasma cells when compared to other hematologic malignancies and normal tissues. DFRF4539A is an anti-FcRH5 antibody-drug conjugated to monomethyl auristatin E (MMAE),... | |||
TMPK-01145 | FcRH5/FcRL5 Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 |
FcRH5 is a cell surface marker enriched on malignant plasma cells when compared to other hematologic malignancies and normal tissues. DFRF4539A is an anti-FcRH5 antibody-drug conjugated to monomethyl auristatin E (MMAE),... | |||
TMPK-00618 | FcRH5/FcRL5 Protein, Human, Recombinant (His) | Human | HEK293 |
FcRH5 is a cell surface marker enriched on malignant plasma cells when compared to other hematologic malignancies and normal tissues. DFRF4539A is an anti-FcRH5 antibody-drug conjugated to monomethyl auristatin E (MMAE),... | |||
TMPK-01039 | FcRH5/FcRL5 Protein, Mouse, Recombinant (His) | Mouse | HEK293 |
FcRH5 is a cell surface marker enriched on malignant plasma cells when compared to other hematologic malignancies and normal tissues. DFRF4539A is an anti-FcRH5 antibody-drug conjugated to monomethyl auristatin E (MMAE),... | |||
TMPH-03008 | ENR Protein, Mycobacterium tuberculosis, Recombinant (His) | Mycobacterium tuberculosis | E. coli |
Enoyl-ACP reductase of the type II fatty acid syntase (FAS-II) system, which is involved in the biosynthesis of mycolic acids, a major component of mycobacterial cell walls. Catalyzes the NADH-dependent reduction of the ... | |||
TMPK-00806 | GHR/Growth Hormone R Protein, Human, Recombinant (His) | Human | HEK293 |
Pegvisomant, a growth hormone receptor (GHR) antagonist, is a well-known drug that was designed to treat acromegaly. However, recent studies have indicated that the GHR is a "moonlighting" protein that may exhibit dual f... | |||
TMPK-01308 | TAG-72 Protein, Canine, Recombinant (His) | Canine | E. coli |
The guanine-N7 methyltransferase domain of vaccinia virus mRNA capping enzyme is a heterodimer composed of a catalytic subunit and a stimulatory subunit. Cap (guanine-N7) methylation is an essential step in eukaryal mRNA... | |||
TMPK-00407 | AXL Protein, Human, Recombinant (His & Avi) | Human | HEK293 |
Axl, a member of the TAM (Tyro3, Axl, Mer) family, and its inhibitors can specifically break the kinase signaling nodes, allowing advanced patients to regain drug sensitivity with improved therapeutic efficacy. Overexpre... | |||
TMPK-00759 | IgG1 Fc Protein, Human, Recombinant | Human | HEK293 |
IgG1 is most abundant in serum among the four IgG subclasses (IgG1, 2, 3 and 4) and binds to Fc receptors (FcγR) on phagocytic cells with high affinity. Fc fragment is demonstrated to mediate phagocytosis, trigger inflam... | |||
TMPJ-01426 | SARS-CoV-2 NSP2 Protein (His) | SARS-CoV-2 | E. coli |
The positive-stranded RNA genome of the coronaviruses is translated from ORF1 to yield polyproteins that are proteolytically processed into intermediate and mature nonstructural proteins (nsps). SARS-CoV 2 polyproteins i... | |||
TMPK-00408 | AXL Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 |
Axl, a member of the TAM (Tyro3, Axl, Mer) family, and its inhibitors can specifically break the kinase signaling nodes, allowing advanced patients to regain drug sensitivity with improved therapeutic efficacy. Overexpre... | |||
TMPK-00410 | AXL Protein (Primary Amine Labeling), Human, Recombinant (hFc), Biotinylated | Human | HEK293 |
Axl, a member of the TAM (Tyro3, Axl, Mer) family, and its inhibitors can specifically break the kinase signaling nodes, allowing advanced patients to regain drug sensitivity with improved therapeutic efficacy. Overexpre... | |||
TMPK-00483 | PCSK9 Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 |
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is an enzyme encoded by the PCSK9 gene in humans on chromosome 1.The first two PCSK9 inhibitors, alirocumab and evolocumab, were approved as once every two week injec... | |||
TMPK-00725 | Hyaluronidase 2/HYAL2 Protein, Mouse, Recombinant (His) | Mouse | HEK293 |
Hyaluronidases, a family of enzymes that are able to degrade hyaluronic acid (HA), are employed in medicine to increase drug diffusion and reverse the effects of HA filler injections. Hyaluronidases are able to dissolve ... | |||
TMPK-00954 | Hyaluronidase 2/HYAL2 Protein, Human, Recombinant (His) | Human | HEK293 |
Hyaluronidases, a family of enzymes that are able to degrade hyaluronic acid (HA), are employed in medicine to increase drug diffusion and reverse the effects of HA filler injections. Hyaluronidases are able to dissolve ... | |||
TMPK-00472 | AXL Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 |
Axl, a member of the TAM (Tyro3, Axl, Mer) family, and its inhibitors can specifically break the kinase signaling nodes, allowing advanced patients to regain drug sensitivity with improved therapeutic efficacy. Overexpre... | |||
TMPY-00520 | MMP-8 Protein, Mouse, Recombinant (His) | Mouse | CHO |
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that degrade components of the extracellular matrix (ECM) and play essential roles in various physiological processes such as morphogenesis, ... | |||
TMPY-03458 | Sorcin/SRI Protein, Human, Recombinant | Human | Baculovirus-Insect Cells |
Sorcin was originally identified in multidrug-resistant cells. It is a calcium-binding protein. Sorcin modulates excitation-contraction coupling in the heart, contributes to calcium homeostasis in the heart sarcoplasmic ... | |||
TMPY-03267 | Sorcin/SRI Protein, Human, Recombinant (His & GST) | Human | Baculovirus-Insect Cells |
Sorcin was originally identified in multidrug-resistant cells. It is a calcium-binding protein. Sorcin modulates excitation-contraction coupling in the heart, contributes to calcium homeostasis in the heart sarcoplasmic ... | |||
TMPK-01384 | SARS PLpro/papain-like protease Protein (His) | SARS | E. coli |
The coronaviral proteases, papain-like protease (PLpro) and 3C-like protease (3CLpro), are attractive antiviral drug targets because they are essential for coronaviral replication. Although the primary function of PLpro ... | |||
TMPY-01844 | MMP-8 Protein, Mouse, Recombinant | Mouse | HEK293 |
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that degrade components of the extracellular matrix (ECM) and play essential roles in various physiological processes such as morphogenesis, ... | |||
TMPY-01377 | MMP-8 Protein, Human, Recombinant (His) | Human | HEK293 |
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that degrade components of the extracellular matrix (ECM) and play essential roles in various physiological processes such as morphogenesis, ... | |||
TMPK-01352 | SARS-CoV-2 PLpro/papain-like protease Protein (His & Avi) | SARS | E. coli |
The coronaviral proteases, papain-like protease (PLpro) and 3C-like protease (3CLpro), are attractive antiviral drug targets because they are essential for coronaviral replication. Although the primary function of PLpro ... | |||
TMPY-00999 | UNC5A Protein, Human, Recombinant (His) | Human | HEK293 |
The netrin-1 receptor Uncoordinated Phenotype-5A, or UNC5A, plays an important role in predicting response to DNA damage induced by chemotherapeutic drug and regulating cell death in bladder cancer. Moreover, UNC5A is cu... | |||
TMPY-00648 | UNC5A Protein, Human, Recombinant (hFc) | Human | HEK293 |
The netrin-1 receptor Uncoordinated Phenotype-5A, or UNC5A, plays an important role in predicting response to DNA damage induced by chemotherapeutic drug and regulating cell death in bladder cancer. Moreover, UNC5A is cu... | |||
TMPK-01158 | Kallikrein 5/KLK5 Protein, Mouse, Recombinant (His) | Mouse | HEK293 |
The inhibition of kallikrein 5 (KLK5) has been identified as a potential strategy for treatment of the genetic skin disorder Netherton syndrome, in which loss-of-function mutations in the SPINK5 gene lead to down-regulat... | |||
TMPY-02442 | ELK1 Protein, Human, Recombinant (His & GST) | Human | Baculovirus-Insect Cells |
E twenty-six (ETS)-like transcription factor 1, also known as Elk1 or Member of ETS oncogene family (ELK1), is a member of the ETS oncogene superfamily which is characterized by a common protein domain that regulates DNA... | |||
TMPK-00875 | CD96 Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 |
The receptors CD96 and TIGIT are expressed on the surface of T and natural killer (NK) cells, and recent studies suggest both play important inhibitory roles in immune function. CD96 has been shown to modulate immune cel... | |||
------------------------ More ------------------------ |
Cat No. | Product Name | ||
---|---|---|---|
L1000 | Approved Drug Library | 2863 compounds | |
A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L2151 | Chemotherapy Drug Library | 51 compounds | |
51 Chemotherapeutic drugs that can be used for high-throughput and high-content screening. | |||
L8800 | Drug-Fragment Library | 1158 compounds | |
1158 drug fragments,a must-have tool for FBDD; | |||
L4200 | FDA-Approved Drug Library | 1729 compounds | |
A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L2150 | Anti-Cancer Drug Library | 3159 compounds | |
A unique collection of 3159 anticancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L9200 | Drug Repurposing Compound Library | 4630 compounds | |
A unique collection of 4630 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L5800 | Drug Metabolite/Impurity Library | 200 compounds | |
A unique collection of 200 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS); | |||
L2152 | Targeted Therapy Drug Library | 121 compounds | |
121 tumor-targeted drugs that can be used for high-throughput and high-content screening. | |||
L2110 | Anti-Cancer Approved Drug Library | 1825 compounds | |
A unique collection of 1825 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L1010 | FDA-Approved & Pharmacopeia Drug Library | 3158 compounds | |
3158 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L6160 | RO5 Drug-like Natural Product Library | 2743 compounds | |
A unique collection of 2743 natural product monomers that meet the "Lipinski's Rule of Five", a powerful tool for HTS and HCS screening; | |||
L5510 | Drug-induced Liver Injury (DILI) Compound Library | 1040 compounds | |
A unique collection of 1040 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening; | |||
L9210 | Pediatric Drug Library | 1015 compounds | |
A unique collection of 1015 pediatric drugs for high-throughput screening and high-content screening. | |||
L1020 | EMA Approved Drug Library | 670 compounds | |
DF4600 | Drug-like natural compound library | 522 compounds | |
L4900 | Cardiotoxicity Compound Library | 132 compounds | |
A unique collection of 132 cardiotoxicity inducing compounds for toxicological study; | |||
L7830 | High Solubility Pharmacophore Fragment Library | 985 compounds | |
High Solubility Pharmacophore Fragment library contains 985 fragment small molecules. | |||
L7820 | High Solubility Micro Fragment Library | 1082 compounds | |
The compound library of highly soluble micro-fragments consists of 1082 low-molecular-weight fragments. | |||
L9230 | ReFRAME Related Library | 3274 compounds | |
A unique collection of 3274 compounds for high-throughput screening and high-content screening, | |||
L2570 | Human Metabolite Library | 4532 compounds | |
A unique collection of 4532 human metabolites for high-throughput, high-content screening. | |||
L9850 | Orally Active Compound Library | 2484 compounds | |
A unique collection of 2484 of orally active compounds for high-throughput screening and high-content screening. | |||
L1500 | GPCR Compound Library | 1940 compounds | |
A unique collection of 1940 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research; | |||
L5610 | Golden Scaffold Library | 10000 compounds | |
Diversity: Selected from 1,600,000 drug-like compounds, 10000compounds representing 5000 scaffolds selected from a large drug-like chemical source; | |||
L1580 | GPCR Compound Library Plus | 338 compounds | |
Well-chosen 338 GPCR targeting compounds with unique structures; | |||
L5600 | Mini Scaffold Library | 5000 compounds | |
Diversity: Selected from 1,600,000 drug-like compounds covering rich chemical scaffolds, 5000 compounds representing 5000 scaffolds; | |||
L7840 | High Solubility FragLite Fragment Library | 796 compounds | |
The highly soluble halogenated fragment library contains 796 halogenated fragment compounds. | |||
L9100 | Phosphatase Inhibitor Library | 80 compounds | |
A collection of 80 phosphatase inhibitors with known activity; | |||
L6010 | Natural Product Library | 3720 compounds | |
A unique collection of 3720 natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L4020 | NO PAINS Compound Library | 9555 compounds | |
TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 9555 small molecules that are suitable for new drug development, signaling pathway research, drug repurposing and other resea... | |||
L4150 | Featured Novel Bioactive Compound Library | 990 compounds | |
It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consis... | |||
L4010 | Bioactive Compounds Library Max | 22706 compounds | |
A collection of 22706 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification. | |||
L9900 | Inactive Ingredient Library | 184 compounds | |
A Collection of 184 inactive ingredients from FDA-approved drugs. | |||
L3400 | Clinical Compound Library | 3480 compounds | |
A unique collection of 3480 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS); | |||
L4510 | Anti-Parasitic Compound Library | 420 compounds | |
420 well-chosen unique anti-parasitic small molecules; | |||
L4600 | Selected Plant-Sourced Compound Library | 3076 compounds | |
A unique collection of 3076 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS); | |||
L1800 | Anti-Infection Compound Library | 2977 compounds | |
A unique collection of 2977 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc; | |||
L2200 | Tyrosine Kinase Inhibitor Library | 1033 compounds | |
A unique collection of 1033 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases; | |||
L1710 | Anti-COVID-19 Compound Library | 1160 compounds | |
A unique collection of 1160 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents; | |||
L4000 | Bioactive Compound Library | 14590 compounds | |
A collection of 14590 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification; | |||
L2300 | Ion Channel Inhibitor Library | 946 compounds | |
A unique collection of 946 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery; | |||
L6110 | Alkaloid Natural Product Library | 468 compounds | |
A unique collection of 468 natural alkaloids can be used for high throughput and high content screening; | |||
L1700 | Anti-Viral Compound Library | 1040 compounds | |
A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening; | |||
L2500 | Human Endogenous Metabolite Library | 508 compounds | |
A collection of 508 selected human endogenous metabolites for high throughput and high content screening. | |||
L6700 | Anti-Tumor Natural Product Library | 1800 compounds | |
A unique collection of 1800 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L2193 | Anti-Liver Cancer Compound Library | 1816 compounds | |
1816 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies. | |||
L9840 | Anti-Alzheimer's Disease Compound Library | 1040 compounds | |
A unique collection of 1040 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS. | |||
L9410 | Covalent Inhibitor Library | 1949 compounds | |
A unique collection of 1949 covalent Inhibitors and other molecules with common warheads like chloroacetyl,2-Chloropropionyl,Acryloyl,sulfonyl fluoride, alkyne,acrylamide, ketocarbonyl,disulfide bond, etc. | |||
L6000 | Natural Product Library for HTS | 4320 compounds | |
A unique collection of 4320 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can... | |||
L4520 | Anti-Bacterial Compound Library | 921 compounds | |
A unique collection of 921 antibacterial bioactive compounds, a powerful tool for antibacterial drug development; | |||
L4710 | Nonsteroidal Anti-Inflammatory Compound Library | 530 compounds | |
530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening. | |||
L7870 | Carboxylic Acid Fragment Library With Solubility | 1807 compounds | |
L7800 | High Solubility Fragment Library | 2731 compounds | |
Structurally diverse, medicinally active, and unique chemistry (strong IP potential); | |||
L6810 | Traditional Chinese Medicine Monomer Library | 2771 compounds | |
A unique collection of 2771 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism; | |||
L5700 | Featured Fragment Library | 246 compounds | |
A unique collection of 246 fragment-like small molecules for FBDD; | |||
L2190 | Anti-Lung Cancer Compound Library | 1735 compounds | |
A unique collection of 1735 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study; | |||
LF1000 | Pre-plated Diversity Sets | 50000 compounds | |
For your convenience, there are Diversity Sets of 5,000, 10,000, 15,000, and 20,000 compounds with no structure overlap. | |||
L6730 | Anti-virus Traditional Chinese Medicine Monomer Library | 270 compounds | |
A collection of 270 TCM monomers with anti-virus activity. An effective tool for drug development and pharmacological studies. | |||
L2010 | Highly Selective Inhibitor Library | 580 compounds | |
A collection of xunm highly selective inhibitors | |||
L4400 | Antibiotics Library | 708 compounds | |
A unique collection of 708 compounds with antibiotic activity for new antibacterial drug screening; | |||
L8100 | Cell Cycle Compound Library | 695 compounds | |
A unique collection of 695 cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L6600 | Anti-Gastroenteritis Natural Product Library | 223 compounds | |
A unique collection of 223 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS); | |||
L9600 | Peptide Compound Library | 800 compounds | |
800 peptides can be used in peptide drug development and signaling transduction and mechanism study; | |||
L5900 | CNS-Penetrant Compound Library | 516 compounds | |
A unique collection of 516 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L9830 | Anti-Parkinson's Disease Compound Library | 908 compounds | |
A unique collection of 908 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS. | |||
L5300 | Mitochondria-Targeted Compound Library | 830 compounds | |
A unique collection of 830 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine; | |||
L6610 | Anti-infective Natural Product Library | 1070 compounds | |
A unique collection of 1070 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS); | |||
L8000 | Stem Cell Differentiation Compound Library | 1213 compounds | |
A unique collection of 1213 stem cell differentiation signaling targeted compounds for high throughput and high content screening; | |||
L2180 | Anti-Cancer Compound Library Plus | 1468 compounds | |
Well-chosen 1468 anti-tumor compounds with unique structures; | |||
L1400 | MAPK Inhibitor Library | 367 compounds | |
A unique collection of 367 compounds targeting MAPK signaling for drug discovery in MAPK related diseases; | |||
L6030 | Natural Product Derivatives Library for CADD | 163000 compounds | |
Large quantity: contains 163,000 natural product derivatives and the number is continuously updating; | |||
L5200 | Anti-Metabolism Disease Compound Library | 1558 compounds | |
A unique collection of 1558 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L9001 | Food Additive Library | 430 compounds | |
430 food additives; | |||
L1900 | Anti-Diabetic Compound Library | 690 compounds | |
A unique collection of 690 diabetes related compounds; | |||
L3600 | Cytokine Inhibitor Library | 613 compounds | |
A unique collection of 613 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery; | |||
L1600 | Kinase Inhibitor Library | 2720 compounds | |
A unique collection of 2720 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases; | |||
L9300 | Macrocyclic Compound Library | 216 compounds | |
216 macrocyclic compounds of known activity for high-throughput, high-content screening; | |||
L2630 | Neuronal Differentiation Compound Library | 680 compounds | |
680 compounds related to neuronal differentiation, suitable for the drug development of nervous system disease. | |||
L6800 | Chinese Pharmacopoeia Natural Product Library | 2070 compounds | |
A unique collection of 2070 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study; | |||
L4500 | Anti-Fungal Compound Library | 253 compounds | |
A unique collection of 253 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation. | |||
L6620 | Antiparasitic Natural Product Library | 253 compounds | |
A unique collection of 253 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS); | |||
L2610 | Neurotransmitter Receptor Compound Library | 1513 compounds | |
A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening; | |||
L2510 | Lipid Metabolism Compound Library | 496 compounds | |
A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). | |||
L8700 | Ferroptosis Compound Library | 800 compounds | |
A unique collection of 800 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study; | |||
L5500 | Toxic Compound Library | 277 compounds | |
A unique collection of 277 toxic substances for high throughput screening (HTS) and high content screening (HCS); | |||
L4660 | Anti-Nervous System Disease Library | 1246 compounds | |
Well-chosen 1246 compounds with unique structures targeting nervous system; | |||
L2195 | Anti-Prostate Cancer Compound Library | 2096 compounds | |
2096 compounds associated with prostate cancer that can be used for high-throughput and high-content screening. | |||
L6100 | Polyphenolic Natural Product Library | 640 compounds | |
A unique collection of 640 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L1510 | Nuclear Receptor Compound Library | 546 compounds | |
A unique collection of 546 nuclear receptor signaling targeted compounds for high throughput and high content screening; | |||
L1100 | Protease Inhibitor Library | 344 compounds | |
A unique collection of 344 protease and proteasome inhibitors for research in chemical genomics, and drug screening; | |||
L6710 | Anti-Inflammatory Traditional Chinese Medicine Compound Library | 1260 compounds | |
A collection of 1260 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study; | |||
L2501 | Human Endogenous Metabolite Compound Library Plus | 1300 compounds | |
A unique collection of 1300 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening. | |||
L2191 | Anti-Breast Cancer Compound Library | 1965 compounds | |
A unique collection of 1965 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study; | |||
L6020 | Selectable Natural Product Library | 16627 compounds | |
A unique collection of 16627 pure natural products with diverse structures and sources covering various plant, animal, and microbe species; | |||
L6400 | Marine Natural Product Library | 148 compounds | |
A unique collection of 148 marine natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L9610 | Cyclic Peptide Library | 58 compounds | |
58 species of cyclic peptide molecules for high-throughput and high-content screening; | |||
L9810 | Anti-Fibrosis Compound Library | 1180 compounds | |
A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS; | |||
L3500 | Histone Modification Compound Library | 480 compounds | |
A unique collection of 480 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L7600 | Chemokine Inhibitor Library | 59 compounds | |
A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening; | |||
L2170 | Immuno-Oncology Compound Library | 454 compounds | |
A unique collection of 454 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening; | |||
L6001 | Mini Fungal Metabolite Natural Product Screening Library | Inquiry | |
L6150 | Covalent Natural Product Library | 596 compounds | |
Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening. | |||
L2160 | Anti-Cancer Active Compound Library | 3250 compounds | |
A unique collection of 3250 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L2192 | Anti-Pancreatic Cancer Compound Library | 2267 compounds | |
A unique collection of 2267 pancreatic cancer related compounds can be used in HTS and HCS; | |||
L2521 | Glycolysis Compound Library | 560 compounds | |
560 glycolysis-related active compounds for high-throughput and high-content screening. | |||
L2100 | Anti-Cancer Compound Library | 7360 compounds | |
A unique collection of 7360 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L6300 | Food as Medicine Compound Library | 1302 compounds | |
A unique collection of 1302 compounds from food as medicine for high throughput and high content screening; | |||
L6900 | Rare Natural Product Library | 180 compounds | |
A unique collection of 180 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS); | |||
L2800 | Serotonin Receptor-Targeted Compound Library | 275 compounds | |
A unique collection of 275 compounds targeting serotonin receptors for high throughput screening and high content screening; | |||
L8200 | Anti-Aging Compound Library | 3324 compounds | |
A unique collection of 3324 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L4100 | TGF-beta/Smad Compound Library | 185 compounds | |
A unique collection of 185 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening; | |||
L6230 | Miao medicine Compound Library | 540 compounds | |
A unique collection of 540 compounds featuring natural product molecules derived from Miao medicine that can be used for high-throughput and high-content screening. | |||
L8110 | Reprogramming Compound Library | 1840 compounds | |
A unique collection of 1840 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening. | |||
L4800 | Angiogenesis related Compound Library | 1370 compounds | |
A unique collection of 1370 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS); | |||
L3700 | JAK-STAT Compound Library | 256 compounds | |
A unique collection of 256 JAK/STAT signaling targeted compounds for high throughput and high content screening; | |||
L6220 | Traditional Mongolian Medicine Compound Library | 960 compounds | |
A collection of 960 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening. | |||
L1720 | Nucleotide Compound Library | 337 compounds | |
A unique collection of 337 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs; | |||
L7500 | Coagulation and Anticoagulation Compound Library | 154 compounds | |
A unique collection of 154 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L6200 | The Yao nationality medicine Library | 225 compounds | |
A collection of 225 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening. | |||
L2140 | Cancer Cell Differentiation Compound Library | 413 compounds | |
A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening; | |||
L7900 | Osteogenesis Compound Library | 320 compounds | |
A unique collection of 320 osteogenesis related compounds for high throughput and high content screening; | |||
L2130 | Anti-Cancer Metabolism Compound Library | 1280 compounds | |
A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); | |||
L1110 | Microtubule-Targeted Compound Library | 155 compounds | |
A unique collection of 155 microtubule-targeted compounds can be used in HTS and HCS; | |||
L2194 | Anti-Colorectal Cancer Compound Library | 1565 compounds | |
1565 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening. | |||
L3100 | Hematopoietic Toxicity Compound Library | 104 compounds | |
A unique collection of 104 compounds with defined hematopoietic toxicity for high throughput and high content drug screening; | |||
L9500 | Target-Focused Phenotypic Screening Library | 1832 compounds | |
A unique collection of 1832 annotated bioactive compounds with clear targets, suitable for phenotypic screening; | |||
L2540 | Gut Microbial Metabolite Library | 614 compounds | |
A unique collection of 614 gut microbial metabolites which can be used for HTS and HCS; | |||
L4700 | Immunology/Inflammation Compound Library | 3483 compounds | |
A unique collection of 3483 anti-inflammation compounds effective for high throughput screening and high content screening. | |||
L4300 | Wnt/Hedgehog/Notch Compound Library | 240 compounds | |
A unique collection of 240 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening; | |||
L5100 | Fluorochemical Library | 583 compounds | |
A unique collection of 583 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS); | |||
L1310 | Cytoskeletal Signaling Pathway Compound Library | 773 compounds | |
A unique collection of 773 cytoskeleton-related compounds, can be used for HTS and HCS; | |||
L7110 | Anti-Hypertension Compound Library | 719 compounds | |
719 hypertension-related small molecules for high-throughput and high-content screening. | |||
L7100 | Anti-Obesity Compound Library | 2286 compounds | |
A unique collection of 2286 anti-obesity compounds for high throughput and high content screening; | |||
L9400 | PPI Inhibitor Library | 490 compounds | |
A unique collection of 490 PPI-related compounds for drug screening; | |||
L2196 | Anti-Ovarian Cancer Compound Library | 1888 compounds | |
A unique collection of 1888 compounds with anti-ovarian cancer therapeutic activity, can be used for anti-ovarian cancer drug discovery and pharmacological study; | |||
L6210 | Tibetan medicine Compound Library | 754 compounds | |
A collection of 754 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening. | |||
L6820 | Tobacco Monomer Library | 750 compounds | |
A unique collection of 750 tobacco monomer compounds for high throughput screening and high content screening; | |||
L6500 | Microbial Natural Product Library | 560 compounds | |
A unique collection of 560 microbial natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L1610 | FDA-Approved Kinase Inhibitor Library | 266 compounds | |
A unique collection of 266 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening. | |||
L6740 | Anti-Colorectal Cancer Traditional Chinese Medicine Compound Library | 386 compounds | |
A collection of 386 TCM monomers with anti-colorectal activity. An effective tool for drug development and pharmacological studies. | |||
L9000 | Apoptosis Compound Library | 1796 compounds | |
A unique collection of 1796 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening; | |||
L1300 | PI3K-AKT-mTOR Compound Library | 425 compounds | |
A unique collection of 425 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling; | |||
L2550 | Glutamine Metabolism Compound Library | 580 compounds | |
A unique collection of 580 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and ... | |||
L6720 | Anti-COVID-19 Traditional Chinese Medicine Compound Library | 1162 compounds | |
A unique collection of 1162 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening; | |||
L8500 | HIF-1 Signaling Pathway Compound Library | 1352 compounds | |
A unique collection of 1352 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies; |